Article Details
Retrieved on: 2025-06-26 00:13:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Boston-based Insilico Medicine published the results of its phase two trial of rentosertib in the Nature Medicine journal, claiming the first ...
Article found on: www.scmp.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here